secwatch.observer — SEC 8-K summary
======================================

Issuer:     Strata Critical Medical, Inc. (SRTA)
CIK:        0001779128
Form:       8-K
Filed at:   2023-08-09T23:59:59+00:00
Accession:  0001779128-23-000075
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Blade Q2 revenue $61M (+71%), medical $34.4M (+99%), net loss $12.2M
--------------------------------------------------------------------

- Q2 revenue $61.0M (+71% YoY); medical revenue $34.4M (+99% YoY, +29% sequentially).
- Flight Profit $10.4M (+103% YoY); Flight Margin 17.0% vs 14.3%.
- GAAP net loss $12.2M vs net income $8.4M in prior-year quarter.
- Adjusted EBITDA -$4.4M vs -$6.1M, improved 27%; Medical Adj. EBITDA $3.0M.
- Short Distance revenue up 75% YoY, driven by Blade Europe acquisition and organic growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779128/000177912823000075/0001779128-23-000075-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779128/000177912823000075/blde-20230809.htm
  HTML page:      https://secwatch.observer/filing/0001779128-23-000075

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer